About Biofield Pharma Private Limited
Data last updated:
Biofield Pharma Private Limited is a private limited company based in Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 November 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24233CH2015PTC035831. Its GSTIN is 04AAGCB5164K1ZN (Chandigarh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Deepshikha and Ashmit Kaushal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at S.C.F. 467 First Floor, Sector 13, Chandigarh, India – 160101.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.51 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹16.72 Lakh (net margin 3%) and EBITDA of ₹19.5 Lakh (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 13% over five years.
The company is associated with 1 brand: Biofield Pharma. Court records list 7 cases involving the company, including 7 filed by the company; 5 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biofieldpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressS.C.F. 467 First Floor, Sector 13, Chandigarh, India – 160101
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Biofield Pharma Private Limited
The main business activity of Biofield Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Biofield Pharma Private Limited FY 2024 filings available
Biofield Pharma Private Limited reported revenue of ₹5.51 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Biofield Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 9% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Biofield Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹19.5 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹16.72 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Biofield Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Biofield Pharma are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Biofield Pharma Private Limited
Biofield Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| R.R.R. Pharma Private Limited | ₹5.55 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Chennai, Tamil Nadu, India |
| Edura Pharmaceuticals Private Limited | ₹5.55 Cr (FY 2025) | •••• | •••• | -14.0% | •••• | New Delhi, Delhi, India |
| Harsoria Medical Private Limited | ₹5.55 Cr (FY 2024) | •••• | •••• | -68.0% | •••• | Punjab, Chandigarh, India |
| CVS Biotech Private Limited | ₹5.54 Cr (FY 2025) | •••• | •••• | -45.0% | •••• | New Delhi, Delhi, India |
| Raj Mandir Retails Private Limited | ₹5.54 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | New Delhi, Delhi, India |
| Biofield Pharma Private Limited this company | ₹5.51 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Chandigarh, India |
| Waymed Lifecare Private Limited | ₹5.49 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Calicut, Kerala, India |
| Sapco Laboratories Private Limited | ₹5.49 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Chennai, Tamil Nadu, India |
| Zovaitalia Healthcare Private Limited | ₹5.49 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Jaipur, Rajasthan, India |
| Mahendra Medical Store Private Limited | ₹5.49 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Mawana, Uttar Pradesh, India |
| Aviator Life Science Private Limited | ₹5.49 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Ahmadabad City, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Biofield Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Biofield Pharma Private Limited
Biofield Pharma Private Limited is audited by ATUL SANGEETA & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ATUL SANGEETA & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Biofield Pharma Private Limited
Biofield Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepshikha Also directs: Stelon Biotech Private Limited | Director | 01 Jul 2023 | 3 Years 3 Months | Current |
| Ashmit Kaushal Also directs: Stelon Biotech Private Limited | Director | 20 Nov 2015 | 10 Years 10 Months | Current |
Ownership and Shareholding of Biofield Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Biofield Pharma Private Limited
Biofield Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Biofield Pharma Private Limited
Biofield Pharma Private Limited has 7 court cases on record: 7 filed by Biofield Pharma. 5 cases are pending and 2 are disposed. Status as checked between 30 Sep 2026 and 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 0 | 5 |
Cases on record (3 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against Biosild Pharma Private Limited | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against an individual | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Evergreen Pharma Associates | Disposed |
Full case history
All 7 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Biofield Pharma Private Limited
Biofield Pharma operates one associated brand: Biofield Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, marketing, and export services in India. | biofieldpharma.com |
Employees and EPFO Compliance at Biofield Pharma Private Limited
Employment history and EPFO contributions of people linked to Biofield Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Biofield Pharma Private Limited
Biofield Pharma Private Limited has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Gopal Krishan Pathak ceased to be Director on 13 Jul 2023.
Credit Ratings, Litigation & Regulatory Alerts for Biofield Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Biofield Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Biofield Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Biofield Pharma Private Limited
Biofield Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAGCB5164K1ZN | Chandigarh | Active | 01 Jul 2017 |
| 06AAGCB5164K1ZJ | Haryana | Active | 19 Feb 2026 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Biofield Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biofield Pharma Private Limited
Biofield Pharma is an active private limited company based in Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 November 2015 (11+ years old) and is registered under CIN U24233CH2015PTC035831.
Biofield Pharma reported revenue of ₹5.51 Cr for FY 2025 (up 9% YoY).
Biofield Pharma has 2 current directors:
- Deepshikha - Director
- Ashmit Kaushal - Director
Biofield Pharma reported a net profit of ₹16.72 Lakh (net margin 3%) and EBITDA of ₹19.5 Lakh (EBITDA margin 3.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Biofield Pharma is 8% over three years and 13% over five years. In the latest year (FY 2025) revenue rose 9%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Biofield Pharma is 04AAGCB5164K1ZN, registered in Chandigarh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAGCB5164K1ZJ (Haryana).
The CIN (Corporate Identification Number) of Biofield Pharma is U24233CH2015PTC035831. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biofield Pharma has 7 court cases on record: 7 filed by the company. 5 are pending.
Biofield Pharma was incorporated on 20 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Biofield Pharma by revenue are R.R.R. Pharma Private Limited, Edura Pharmaceuticals Private Limited, Harsoria Medical Private Limited, CVS Biotech Private Limited, Raj Mandir Retails Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Gopal Krishan Pathak ceased to be Director on 13 Jul 2023. Deepshikha was appointed as Director on 01 Jul 2023. Ashmit Kaushal was appointed as Director on 20 Nov 2015.